Patents by Inventor Pierre Ducray

Pierre Ducray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260070879
    Abstract: The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
    Type: Application
    Filed: November 14, 2025
    Publication date: March 12, 2026
    Inventors: Pierre DUCRAY, Denise RAGEOT
  • Patent number: 12497370
    Abstract: The present invention provides isoxazoline derivatives of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: December 16, 2025
    Assignee: Elanco Tiergesundheit AG
    Inventors: Pierre Ducray, Denise Rageot
  • Patent number: 12448391
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: October 21, 2025
    Assignee: Elanco Tiergesundheit AG
    Inventors: Pierre Ducray, Francois Pautrat, Denise Rageot, Chouaib Tahtaoui
  • Publication number: 20240360116
    Abstract: The present invention provides compounds of formula (I?): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: December 3, 2021
    Publication date: October 31, 2024
    Inventors: Francois PAUTRAT, Chouaib TAHTAOUI, Pierre DUCRAY, Denise RAGEOT
  • Publication number: 20240287005
    Abstract: The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
    Type: Application
    Filed: June 15, 2022
    Publication date: August 29, 2024
    Inventors: Pierre DUCRAY, Denise RAGEOT, Andreas TURBERG
  • Publication number: 20240270729
    Abstract: The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, optionally fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
    Type: Application
    Filed: June 15, 2022
    Publication date: August 15, 2024
    Inventors: Pierre Ducray, Denise Rageot, Andreas Turberg
  • Publication number: 20240059680
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: November 17, 2021
    Publication date: February 22, 2024
    Inventors: Nils GRIEBENOW, Chouaib TAHTAOUI, Pierre DUCRAY, Denise RAGEOT
  • Publication number: 20220242857
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: June 5, 2020
    Publication date: August 4, 2022
    Inventors: Pierre DUCRAY, Francois PAUTRAT, Denise RAGEOT, Chouaib TAHTAOUI
  • Publication number: 20220064159
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: December 13, 2019
    Publication date: March 3, 2022
    Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
  • Publication number: 20220064160
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: December 13, 2019
    Publication date: March 3, 2022
    Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
  • Publication number: 20210188789
    Abstract: The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
    Type: Application
    Filed: December 17, 2020
    Publication date: June 24, 2021
    Inventors: Pierre DUCRAY, Denise RAGEOT
  • Publication number: 20200385398
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Inventors: Pierre DUCRAY, Denise RAGEOT, Chouaib TAHTAOUI, Francois PAUTRAT
  • Patent number: 10370375
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: August 6, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Publication number: 20180346465
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Patent number: 10059709
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: August 28, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Publication number: 20170050965
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: March 25, 2015
    Publication date: February 23, 2017
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Patent number: 8940782
    Abstract: The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) as described herein. Further, the present invention is directed to corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: January 27, 2015
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Tania Cavaliero, Maike Renner, Jacques Bouvier
  • Publication number: 20130143924
    Abstract: The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) as described herein. Further, the present invention is directed to corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin.
    Type: Application
    Filed: November 16, 2012
    Publication date: June 6, 2013
    Inventors: Pierre DUCRAY, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
  • Patent number: 8338490
    Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 25, 2012
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
  • Patent number: 7964635
    Abstract: The invention relates to compounds of the general formula (I) wherein X, Y and W have the significances given in claim 1 and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites in and on warm-blooded animals.
    Type: Grant
    Filed: January 8, 2009
    Date of Patent: June 21, 2011
    Assignee: Novartis AG
    Inventors: Noëlle Gauvry, Thomas Goebel, Pierre Ducray, François Pautrat, Ronald Kaminsky, Martin Jung